ABSTRACT:In previous studies, we have shown that phosphonium salt diphenyl derivatives are attractive antitrypanosomal hit compounds with EC 50 values against Trypanosoma brucei in the nanomolar range. To evaluate the role of the cationic center on the trypanocidal activity and extend the structure−activity relationship (SAR) of this series, trialkylammonium, pyridinium, and quinolinium salt analogues were synthesized and evaluated in vitro against T. b. brucei. Similar SARs were observed with ammonium and phosphonium salts showing that charge dispersion and lipophilic groups around the cationic center are crucial to obtain submicromolar activities. The new compounds were equally effective against wild type (T. b. brucei s427) and resistant strains (TbAT1-KO and TbB48) of trypanosomes indicating that the P2 and high affinity pentamidine transporters (HAPT) are not essential to their trypanocidal action. Similarly to phosphonium salt derivatives, diffusion seems to be the main route of entry into trypanosomes. KEYWORDS: Trypanosoma brucei, ammonium salt, quinolinium salt, pyridinium salt, P2-transporter, high affinity pentamidine transporter (HAPT) P arasitic protozoa of the genus Trypanosoma cause human and animal trypanosomiases in Africa. Two subspecies of T. brucei (T. b. gambiense and T. b. rhodesiense) are pathogenic to man and cause human African trypanosomiasis (HAT) in sub-Saharan Africa. In contrast, T. b. brucei, T. congolense, and T. vivax cause veterinary diseases in domestic and wild animals. 1,2 African trypanosomiasis is one of the most neglected tropical diseases as shown by the lack of safe drugs to treat both (early and late) stages of the illness. These drugs, which have been used for decades, are subject to treatment failure (drug resistance) and have severe drawbacks such as unacceptable toxicity and parenteral administration. 3 Cationic drugs are an important class of trypanocides used for the treatment of human and veterinary trypanosomiasis (e.g., pentamidine, diminazene, homidium, and isomethamidium). 4,5 In previous studies we have shown that a new class of cationic compounds, mono-and bisphosphonium salt derivatives with a diphenyl scaffold, have submicromolar activities against T. brucei and Leishmania parasites. 6,7 These compounds display a good selectivity index relative to human cell lines, are not cross-resistant with existing trypanocides, and require only a short exposure time for trypanocidal activity. 6 Like other dicationic trypanocides, 8,9 the bisphosphonium salts are expected to accumulate in the mitochondria. Indeed, a mitochondrial target for these compounds was demonstrated in Leishmania. 7 Structure−activity relationship (SAR) studies revealed that bulky substituents on the phosphorus atoms are required to achieve submicromolar EC 50 values within this series. In the present work, we wanted to learn whether the nature of the cationic center was important for the observed trypanocidal activity of these hit compounds. Thus, new cationic analogues of the hits with a nitr...